Glenmark Pharmaceuticals Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th September, 2025
26 Sep 2025
The Board approved Interim Dividend of Rs. 2.50 per equity shares on face value of Re. 1/- per equity shares for the Financial Year 2025-26 and reconstitution of Committees.
Source:
BSE India